The strength of this study lies in its systematic integration of bioinformatics, multiplex immunohistochemistry, and preclinical models, comprehensively validating the biological function of ALG3 in the HCC immune microenvironment. This evidence concerns the gene ALG3 and hepatocellular carcinoma.